Ikris Pharma
About Us Named Patient Program
Contact Us
Erwinase

Sourced directly from the authorized manufacturer network to ensure authenticity and quality.

You can also access detailed information by clicking Login in the website header.

Erwinase

Supplied with complete CDSCO-approved import and customs documentation, including Form 12A & 12B, CDEC, GST Bill of Entry, Commercial Invoice, and Packing List.

Medicine Name: Erwinase
Generic Name (API): Asparaginase Erwinia chrysanthemi
Dosage Form & Strength: 10,000 IU
Route: Intramuscular or intravenous injection
Drug Class: Asparagine-depleting enzyme (Erwinia-derived asparaginase)

Manufacturer / Innovator:

Germany

Regulatory Approval:

  • Approved in Europe/UK (the same active ingredient is marketed in the US as Erwinaze)
Family enjoying life with Named Patient Program access

Your Trustedworthy Partner For Named Patient Program

  • your trusted partner for named patient program

    Over a decade of trusted expertise in Named Patient Access to innovative and life-saving medicines.

  • 100% CDSCO-compliant processes ensuring safe, ethical, and responsible medicine access.

    100% CDSCO-compliant processes ensuring safe, ethical, and responsible medicine access.

  • Medicines sourced from authorized manufacturers with full batch traceability

    Medicines sourced from authorized manufacturers with full batch traceability.

  • EU-GDP Compliant Warehousing for secure, quality-controlled global distribution.

    EU-GDP compliant warehousing for secure, quality-controlled global distribution.

  • Temperature-Controlled Logistics for Safe and Timely Delivery

    Temperature-controlled logistics ensuring safe, reliable, and timely medicine delivery.

GDP Compliant
Licensed Wholesale distributor

What Is Erwinase Used For?

Erwinase (asparaginase Erwinia chrysanthemi) is an enzyme that depletes asparagine, an amino acid leukemia cells need to survive. It is indicated for:

  • Treatment of acute lymphoblastic leukemia (ALL), as part of a multi-agent chemotherapy regimen, in patients who have developed hypersensitivity to E. coli-derived asparaginase

Erwinase is a prescription medicine and must be administered under the supervision of a qualified oncologist experienced in treating ALL.

Recommended Dosage

  • Dosing is individualized as part of a multi-agent chemotherapy protocol, typically given intramuscularly or intravenously multiple times per week
  • The treating oncologist will determine the specific dose and schedule based on the chemotherapy protocol being followed

This information is not a treatment plan. For personalized medical advice, consult your doctor and refer to the full prescribing information.

Erwinase Warnings and Precautions

  • Hypersensitivity reactions: Serious allergic reactions, including anaphylaxis, can occur even though Erwinase is used specifically for patients allergic to E. coli-derived asparaginase.
  • Pancreatitis: Severe or hemorrhagic pancreatitis can occur; treatment should be discontinued if this develops.
  • Glucose intolerance: Can occur and may be irreversible in some cases; blood glucose should be monitored.
  • Thrombotic events: Serious blood clots, including sagittal sinus thrombosis and pulmonary embolism, have been reported.
  • Bleeding and coagulation abnormalities: Coagulation parameters should be monitored during treatment.

How to Access Erwinase in India: A 6-Step Process

Step 1 – Search & request your medicine: The treating hospital submits a request with basic details to initiate the access process.

Step 2 – Verification & eligibility review: The team verifies availability and reviews eligibility against regulatory and clinical requirements to ensure a compliant pathway.

Step 3 – Receive quote & delivery timeline: A transparent quotation is shared, covering medicine cost, logistics, and a clear delivery timeline.

Step 4 – Regulatory approval process: Assistance is provided to secure the approvals and documentation required for legal cross-border access.

Step 5 – Temperature-controlled import & handling: The medicine is sourced and transported under strict GDP-compliant, cold-chain conditions to maintain product integrity.

Step 6 – Secure delivery: The medicine is delivered to the treating hospital, with updates provided at each stage.

Note: From request to delivery, every step is designed to ensure your treatment reaches you safely, compliantly, and without unnecessary delays.

Documentation & Availability

What documents are required to import Erwinase to India?

Erwinase (asparaginase Erwinia chrysanthemi) injection may be imported in the patient's name only, by patients or government hospitals, in line with India's import regulations for unapproved medicines. The following documentation is required:

  • A valid prescription from a qualified pediatric or medical oncologist
  • The patient's diagnostic reports confirming ALL and hypersensitivity to E. coli-derived asparaginase
  • Patient ID proof (issued by the Government of India)

How is the order confirmed?

The order is confirmed only after receipt and verification of a valid prescription from the doctor and, if applicable, an import permit.

Is Erwinase available in India?

Erwinase (asparaginase Erwinia chrysanthemi injection) is a prescription medicine that legally requires a doctor's prescription to be dispensed. As of current publicly available information, Erwinase is not commercially marketed in India.

However, patients in India can legally access Erwinase through the Named Patient Program (NPP) — an import provision that allows patients to receive medicines approved in other countries but not yet marketed in India, under a doctor's prescription and proper regulatory documentation.

Erwinase is approved in Europe and the UK for ALL patients hypersensitive to E. coli-derived asparaginase, ensuring full transparency throughout the process.

Erwinase can be made available to patients, doctors, and hospitals across major cities in India, including Gurgaon, Delhi, Bangalore, Mumbai, Navi Mumbai, Thane, Hyderabad, Mysore, Kerala, Chennai, Coimbatore, Madurai, Kolkata, Ahmedabad, Surat, Vadodara, Pune, Nagpur, Nashik, Jaipur, Udaipur, Lucknow, Kanpur, Gorakhpur, Chandigarh, Mohali, Faridabad, Noida, Ghaziabad, Kochi, Trivandrum, Kozhikode, Thrissur, Kannur, Mangalore, Bhubaneswar, Patna, Ranchi, Raipur, Guwahati, Visakhapatnam, Vijayawada, Goa, Jammu, Srinagar, Dehradun, Bhopal, Indore, Ludhiana, Amritsar, and others.

The same active ingredient is also marketed as Erwinaze in the US; NPP can source either brand depending on availability.

Sourcing & Delivery of Erwinase

Erwinase is sourced directly from authorized channels in the country of origin and shipped to India under GDP-compliant, cold-chain logistics to preserve product integrity from dispatch to delivery.

  • Cold-chain shipping maintained at 2°C to 8°C throughout transit
  • Real-time shipment tracking and delivery updates
  • Delivery coordinated directly with the treating hospital

Availability of Erwinase Across Major Cities in India

Named Patient Program supports hospital access to Erwinase for ALL patients hypersensitive to E. coli-derived asparaginase across major cities in India, coordinating documentation, sourcing, and delivery with treating oncologists.

Mumbai

Hospitals in Mumbai can access Erwinase through NPP with support from treating pediatric and medical oncologists.

Delhi

In Delhi, NPP coordinates with hospitals to facilitate timely access to Erwinase for ALL treatment protocols.

Bangalore

Bangalore's oncology centers work with NPP to support patients requiring Erwinase.

Chennai

Hospitals in Chennai can access Erwinase through NPP, with coordination between hospital pharmacy and the program's regulatory and logistics team.

Hyderabad

Hyderabad's oncology centers support access coordination for Erwinase through NPP.

Kolkata

NPP facilitates access to Erwinase for hospitals in Kolkata for ALL chemotherapy protocols.

Pune

Hospitals in Pune can access Erwinase through NPP with prescription-based coordination and cold-chain delivery support.

Ahmedabad

NPP supports access to Erwinase for hospitals in Ahmedabad.

Kochi

Hospitals in Kochi and across Kerala can access Erwinase through NPP's regulated import pathway.

Chandigarh

NPP coordinates access to Erwinase for hospitals in Chandigarh and the surrounding region.

Jaipur

Hospitals in Jaipur can access Erwinase through NPP for ALL treatment protocols.

Lucknow

NPP facilitates access to Erwinase for hospitals in Lucknow and across Uttar Pradesh.

Bhubaneswar

Hospitals in Bhubaneswar can access Erwinase through NPP's coordinated import and delivery process.

Guwahati

NPP supports access to Erwinase for hospitals in Guwahati and across the Northeast region.

NPP also supports hospitals in other Indian cities not listed above — contact the team to check availability and timelines for your location.

Written By:

Written By: Nitin Goswami, Senior Medical Content Writer
Last Updated: 09 September 2026
Sources: FDA • CDSCO

Medically Reviewed By:

Medically Reviewed By: Shilpi Banerjee, Registered Pharmacist (M.Pharm)
Last Updated: 09 September 2026

TRUSTED BY HEALTHCARE PROFESSIONALS & HOSPITALS

Need Help
Accessing Medicines?

Our specialists are here to guide you through every step of the medicine access process.

Let's us help!

Send us a message

Read how to access medicines

Read More arrow icon

Frequently Asked
Questions

Read More